Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-04-10

Clinical Trial Update: Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the anti-proteinuric effect of calcitriol in patients with non-diabetic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitriol (calcitriol)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Proteinuria | Phase 4 | Status: UNKNOWN